Funded by the European Union
Hoffmann-La Roche is a Swiss multinational healthcare company that operates on pharmaceuticals and diagnostics. It was founded in 1896 and in time has established itself as one of the major worldwide pharmaceutical actor with almost 100.000 employees. La Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people's lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Organic chemistry lab, Single-crystal X-ray diffractometer, X-ray powder diffractometer, Atomic force microscope (AFM), Raman spectroscopy, IR-spectroscopy, TEM.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska Curie grant agreement No 956099.